abciximab FDA Link

a monoclonal antibody Fab fragment that blocks the platelet glycoprotein IIb/IIIa receptor & potently inhibits platelet aggregation; used in treatment of refractory unstable angina

Also Known As:

ReoPro; CentoRx; Clotinab; Eli Lilly brand of abciximab; Lilly brand of abciximab; c7E3 Fab; chimeric 7E3 Fab

Pharmalogical Action Categories:

Anticoagulants
Platelet Aggregation Inhibitors

-

Amino Acids, Peptides, and Proteins

-

Proteins: 58433

-

Blood Proteins: 3862

-

Serum Globulins: 74

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Monoclonal Antibodies: 16025

*

abciximab: 831

-

Immunoglobulin Fragments: 354

-

Immunoglobulin Fab Fragments: 398

*

abciximab: 831

-

Immunoproteins: 30

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Monoclonal Antibodies: 16025

*

abciximab: 831

-

Immunoglobulin Fragments: 354

-

Immunoglobulin Fab Fragments: 398

*

abciximab: 831

-

Globulins: 305

-

Serum Globulins: 74

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Monoclonal Antibodies: 16025

*

abciximab: 831

-

Immunoglobulin Fragments: 354

-

Immunoglobulin Fab Fragments: 398

*

abciximab: 831

Barry Oemar Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure